<DOC>
	<DOCNO>NCT02948621</DOCNO>
	<brief_summary>The endoscopic sleeve gastroplasty allow stomach size reduction endoluminal suture approach without incision . It could reduce complication associate current surgical technique obtain target gastric restriction , weight loss , comorbidities quality life improvement . The primary objective study assess weight loss endoscopic sleeve gastroplasty patient morbid obesity .</brief_summary>
	<brief_title>Endoscopic Sleeve Gastroplasty</brief_title>
	<detailed_description>Gastric restriction one fundamental principle gastric bypass gastric banding . Nowadays , practitioner possibility reduce stomach size merge tissue endoscopic endoluminal suture approach without incision . This could reduce complication associate current surgical technique obtain target gastric restriction , weight loss , comorbidities quality life improvement . The primary objective study assess weight loss endoscopic sleeve gastroplasty patient morbid obesity accord technique described literature : reduction gastric pouch sleeve structure modification stomach great curvature thanks plication .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Patient &gt; 18 year old &lt; 60 year old Patient morbid obesity least 2 year Patient fail medical diet treatment obesity Patient contraindication anesthesia Patient able understand study provide inform consent . Patient inflammatory , tumoral bad quality tissue endoscopy Patient history gastrointestinal inflammatory disease , stenosis intestinal adhesion , kidney liver failure , chronic pancreatic disease Patient history and/or sign and/or symptom gastroduodenal ulcerous disease and/or progressive gastroduodenal ulcerous disease Patient oesophageal pathology Zenker 's diverticulum , peptic oesophagitis stage 34 , oesophageal stenosis , Barrett syndrome , oesophageal cancer , dysphagia , achalasia Patient previous bariatric , gastric oesophageal surgery , intestinal obstruction , portal hypertension , gastrointestinal tumor , oesophageal gastric varix , gastroparesis Patient severe coagulopathy ( prothrombin time &gt; 3 second thrombocytic count &lt; 50 000/mm3 ) treat heparin , coumadin , warfarin anticoagulant drug prevent coagulation platelet aggregation , except aspirin nonsteroidal antiinflammatory drug Pregnancy , breastfeed woman without contraception Patient congestive heart failure , arrhythmia unstable coronary heart disease Patient use use diet drug within last 30 day intend use study followup Patient drug treatment within last 3 month know induce weight gain Patient eat disorder uncontrolled , poorly control suspect psychiatric disease Patient poor condition accord investigator Patient exclusion period ( determine previous study progress ) Patient significative weight loss date enrollment study date procedure Patient systemic infection day procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Endoscopic sleeve gastroplasty</keyword>
	<keyword>Excess weight loss</keyword>
	<keyword>Quality life</keyword>
</DOC>